Cargando…
Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy
The increasing frequency of infections caused by multidrug-resistant Klebsiella pneumoniae demands the development of unconventional therapies. Here, we isolated, characterized, and sequenced a Klebsiella phage PG14 that infects and lyses carbapenem-resistant K. pneumoniae G14. Phage PG14 showed mor...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769620/ https://www.ncbi.nlm.nih.gov/pubmed/36374021 http://dx.doi.org/10.1128/spectrum.01994-22 |
_version_ | 1784854411030298624 |
---|---|
author | Mulani, Mansura S. Kumkar, Shital N. Pardesi, Karishma R. |
author_facet | Mulani, Mansura S. Kumkar, Shital N. Pardesi, Karishma R. |
author_sort | Mulani, Mansura S. |
collection | PubMed |
description | The increasing frequency of infections caused by multidrug-resistant Klebsiella pneumoniae demands the development of unconventional therapies. Here, we isolated, characterized, and sequenced a Klebsiella phage PG14 that infects and lyses carbapenem-resistant K. pneumoniae G14. Phage PG14 showed morphology similar to the phages belonging to the family Siphoviridae. The adsorption curve of phage PG14 showed more than 90% adsorption of phages on a host within 12 min. A latent period of 20 min and a burst size of 47 was observed in the one step growth curve. Phage PG14 is stable at a temperature below 30°C and in the pH range of 6 to 8. The PG14 genome showed no putative genes associated with virulence and antibiotic resistance. Additionally, it has shown lysis against 6 out of 13 isolates tested, suggesting the suitability of this phage for therapeutic applications. Phage PG14 showed more than a 7-log cycle reduction in K. pneumoniae planktonic cells after 24 h of treatment at a multiplicity of infection (MOI) of 10. The phage PG14 showed a significant inhibition and disruption of biofilm produced by K. pneumoniae G14. The promising results of this study nominate phage PG14 as a potential candidate for phage therapy. IMPORTANCE Klebsiella pneumoniae is one of the members of the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) group of pathogens and is responsible for nosocomial infections. The global increase of carbapenem-resistant K. pneumoniae has developed a substantial clinical threat because of the dearth of therapeutic choices available. K. pneumoniae is one of the commonly found bacteria responsible for biofilm-related infections. Due to the inherent tolerance of biofilms to antibiotics, there is a growing need to develop alternative strategies to control biofilm-associated infections. This study characterized a novel bacteriophage PG14, which can inhibit and disrupt the K. pneumoniae biofilm. The genome of phage PG14 does not show any putative genes related to antimicrobial resistance or virulence, making it a potential candidate for phage therapy. This study displays the possibility of treating infections caused by multidrug-resistant (MDR) isolates of K. pneumoniae using phage PG14 alone or combined with other therapeutic agents. |
format | Online Article Text |
id | pubmed-9769620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-97696202022-12-22 Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy Mulani, Mansura S. Kumkar, Shital N. Pardesi, Karishma R. Microbiol Spectr Research Article The increasing frequency of infections caused by multidrug-resistant Klebsiella pneumoniae demands the development of unconventional therapies. Here, we isolated, characterized, and sequenced a Klebsiella phage PG14 that infects and lyses carbapenem-resistant K. pneumoniae G14. Phage PG14 showed morphology similar to the phages belonging to the family Siphoviridae. The adsorption curve of phage PG14 showed more than 90% adsorption of phages on a host within 12 min. A latent period of 20 min and a burst size of 47 was observed in the one step growth curve. Phage PG14 is stable at a temperature below 30°C and in the pH range of 6 to 8. The PG14 genome showed no putative genes associated with virulence and antibiotic resistance. Additionally, it has shown lysis against 6 out of 13 isolates tested, suggesting the suitability of this phage for therapeutic applications. Phage PG14 showed more than a 7-log cycle reduction in K. pneumoniae planktonic cells after 24 h of treatment at a multiplicity of infection (MOI) of 10. The phage PG14 showed a significant inhibition and disruption of biofilm produced by K. pneumoniae G14. The promising results of this study nominate phage PG14 as a potential candidate for phage therapy. IMPORTANCE Klebsiella pneumoniae is one of the members of the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) group of pathogens and is responsible for nosocomial infections. The global increase of carbapenem-resistant K. pneumoniae has developed a substantial clinical threat because of the dearth of therapeutic choices available. K. pneumoniae is one of the commonly found bacteria responsible for biofilm-related infections. Due to the inherent tolerance of biofilms to antibiotics, there is a growing need to develop alternative strategies to control biofilm-associated infections. This study characterized a novel bacteriophage PG14, which can inhibit and disrupt the K. pneumoniae biofilm. The genome of phage PG14 does not show any putative genes related to antimicrobial resistance or virulence, making it a potential candidate for phage therapy. This study displays the possibility of treating infections caused by multidrug-resistant (MDR) isolates of K. pneumoniae using phage PG14 alone or combined with other therapeutic agents. American Society for Microbiology 2022-11-14 /pmc/articles/PMC9769620/ /pubmed/36374021 http://dx.doi.org/10.1128/spectrum.01994-22 Text en Copyright © 2022 Mulani et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Mulani, Mansura S. Kumkar, Shital N. Pardesi, Karishma R. Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy |
title | Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy |
title_full | Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy |
title_fullStr | Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy |
title_full_unstemmed | Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy |
title_short | Characterization of Novel Klebsiella Phage PG14 and Its Antibiofilm Efficacy |
title_sort | characterization of novel klebsiella phage pg14 and its antibiofilm efficacy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769620/ https://www.ncbi.nlm.nih.gov/pubmed/36374021 http://dx.doi.org/10.1128/spectrum.01994-22 |
work_keys_str_mv | AT mulanimansuras characterizationofnovelklebsiellaphagepg14anditsantibiofilmefficacy AT kumkarshitaln characterizationofnovelklebsiellaphagepg14anditsantibiofilmefficacy AT pardesikarishmar characterizationofnovelklebsiellaphagepg14anditsantibiofilmefficacy |